<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02594306</url>
  </required_header>
  <id_info>
    <org_study_id>EEG/ERP and drug addiction</org_study_id>
    <nct_id>NCT02594306</nct_id>
  </id_info>
  <brief_title>Brain Electrophysiological Study(EEG/ERP) on Opiate Addicts Treating by Bilateral NAc/ALIC Deep Brain Stimulation</brief_title>
  <official_title>Brain Electrophysiological Study(EEG/ERP) on Opiate Addicts Treating by Bilateral NAc/ALIC Deep Brain Stimulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tang-Du Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tang-Du Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Drug addiction is compulsive and spontaneous drug-taking behavior which is characterized by
      non-medical usage, long and repeated exposure to addictive drugs and gradually increasing
      drug-taking dosage and frequency,and become a main threat against human being's public
      health, economic development and social safety.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Effective treatments for severe drug addiction are limited. China centers employing
      compulsory detoxification, reported a 3 year abstinence rate of only 15%. For the methadone
      maintenance therapy, relapse often occurs promptly after cessation of methadone. A Malaysian
      reports about taking naltrexone or buprenorphine treating,showed average relapsed time of 2
      or 3 months,respectively.

      Assessment for psychological craving degree of addiction patients is also a difficult thing.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2015</start_date>
  <completion_date type="Anticipated">November 2016</completion_date>
  <primary_completion_date type="Anticipated">November 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Event related potentials(ERPs)</measure>
    <time_frame>Day 3</time_frame>
    <description>Event related potentials include late positive potential（LPP),P300,mismatch negativity(MMN) and N400.Recording the event related potential when people receive the stimulus of emotional pictures stimulation system.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>local field potential(LFP)</measure>
    <time_frame>in surgery,3 days after surgery</time_frame>
    <description>Recording the LFP of DBS group without any stimulation and stimulate one contact in surgery and 3 days after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the 13-item obsessive compulsive drug use scale(OCDUS)</measure>
    <time_frame>day 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opiate Addiction Severity Inventory(OASI)</measure>
    <time_frame>day 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>participants' craving for opioid drugs (VAS)</measure>
    <time_frame>day 3</time_frame>
    <description>The 10-point visual analog scale(VAS)will be utilized at day 3.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Symptom Checklist-90(SCL-90)</measure>
    <time_frame>day 3</time_frame>
    <description>The Symptom Checklist-90(SCL-90) is used to evaluate general status.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-Rating Depression Scale(SDS)</measure>
    <time_frame>day 3</time_frame>
    <description>Self-Rating Depression Scale(SDS) is used to evaluate depression symptom.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Yale-Brown Obsessive Compulsive Scale(Y-BOCS)</measure>
    <time_frame>day 3</time_frame>
    <description>Yale-Brown Obsessive Compulsive Scale(Y-BOCS) is used to evaluate obsessive compulsive symptom.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Eysenck Personality Questionnaire(EPQ)</measure>
    <time_frame>day 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Wechsler Memory Scale(WMS)</measure>
    <time_frame>day 3</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Substance-Related Disorders</condition>
  <arm_group>
    <arm_group_label>Non operation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Recording the event related potential of drug addicts when they receive the stimulus of Emotional pictures stimulation system.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Deep brain stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Recording the event related potential after the deep brain stimulation operation.Recording the local field potential of drug addiction people when we conduct a test of adjacent contact stimulation in the deep brain stimulation operation. Recording the waveform of bilateral NAc/ALIC after puting the microelectrodes into bilateral nucleus accumbens and anterior limb of the internal capsule</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Recording the event related potential of normal people when they receive the stimulus of emotional pictures stimulation system.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Emotional pictures stimulation system</intervention_name>
    <description>Emotional pictures stimulation system is component of neutral and drug-related images.</description>
    <arm_group_label>Non operation</arm_group_label>
    <arm_group_label>Deep brain stimulation</arm_group_label>
    <arm_group_label>Standard Control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Deep brain stimulation</intervention_name>
    <description>Deep brain stimulation of bilateral NAc/ALIC</description>
    <arm_group_label>Deep brain stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>adjacent contact stimulation</intervention_name>
    <description>The electrode of deep brain stimulation has four contacts.We stimulate one contact,and record the local field potential of other contacts.</description>
    <arm_group_label>Deep brain stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>microelectrode</intervention_name>
    <description>We put the microelectrodes into bilateral nucleus accumbens and anterior limb of the internal capsule,to record the waveform of bilateral NAc/ALIC.</description>
    <arm_group_label>Deep brain stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age between 18 and 65 years of age, male or female；

          2. Opiate addictive over 3 years；

          3. Physical detoxification completed（keep abstinent for at least 7 days，acute abstinent
             syndrome disappeared，morphine urinalysis and naloxone test showed negative)；

          4. No obvious neuropsychiatry and personality disorders；

          5. No severe infectious disease；

          6. Good compliance and be able to complete follow up；

          7. General health is good，no severe liver、kidney、heart and lung disease；

          8. Informed consent issued

        Exclusion Criteria:

          1. Severe cognitive disorders（MMSE scale: illiteracy≤17，primary school≤20，secondary
             school or above≤24）,bad compliance because of dementia,unable to issue the informed
             content；

          2. History of severe neuropsychiatric disease；

          3. Epilepsy；

          4. severe liver、kidney、heart and lung disease, severe hypertension and severe orthostatic
             hypotension；

          5. Malignant tumor；History of brain trauma；Pregnant female；

          6. Patients are taking part in other clinical trials in recent 3 months；

          7. Being deem as unfit for the trials by researcher.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guo-dong Gao, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Department of neurosurgery, Tangdu Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Guo-dong Gao, M.D.</last_name>
    <phone>+86 29 84777435</phone>
    <email>gguodong@fmmu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Xue-lian Wang, M.D.</last_name>
    <phone>+86 29 84777284</phone>
    <email>wxlian@fmmu.edu.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of neurosurgery, Tangdu Hospital</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <zip>710038</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guo-dong Gao, M.D.</last_name>
      <phone>+86 29 84777435</phone>
      <email>gguodong@fmmu.edu.cn</email>
    </contact>
    <investigator>
      <last_name>Xue-lian Wang, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 14, 2015</study_first_submitted>
  <study_first_submitted_qc>November 2, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 3, 2015</study_first_posted>
  <last_update_submitted>February 17, 2016</last_update_submitted>
  <last_update_submitted_qc>February 17, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 19, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tang-Du Hospital</investigator_affiliation>
    <investigator_full_name>Guodong Gao</investigator_full_name>
    <investigator_title>Neurosurgery Department</investigator_title>
  </responsible_party>
  <keyword>drug addiction</keyword>
  <keyword>Heroin</keyword>
  <keyword>craving</keyword>
  <keyword>event related potential</keyword>
  <keyword>crystal methamphetamine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Substance-Related Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

